Home LiteratureArticle Details
PMID: 8040321 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Individual and synergistic effects of rabbit granulocyte proteins on Escherichia coli.

The Journal of clinical investigation ·Vol. 94 ·No. 2 ·1994-08-00 ·Pages 672-82

Levy O, Ooi CE, Weiss J, Lehrer RI, Elsbach P

Abstract

Affinity purification of crude acid extracts of rabbit polymorphonuclear leukocytes using Escherichia coli (J5) as adsorbent yields the bactericidal/permeability-increasing protein (BPI), two 15-kD species (p15s), and the two most potent (cationic) defensin species (neutrophil peptides [NP] -1 and -2). Tested in buffered isotonic medium, the relative antibacterial potency of these proteins against E. coli J5 is BPI (IC50 0.2 nM) > p15A (10 nM) > NP -1 (400 nM). Sublethal doses of p15A or NP-1 can synergize with BPI to decrease the dose required to inhibit the growth of E. coli by up to 50-fold. BPI and p15A display similar features of antibacterial action distinct from defensin NP-1, but NP-1 acts synergistically only with BPI and not with p15A. All aspects of the combined action of BPI and NP-1 resemble those observed with higher concentrations of BPI alone, implying that NP-1 enhances BPI potency. Neither NP-1 nor p15A alter the amount of BPI binding to E. coli but BPI enhances binding of p15A to E. coli, raising the possibility that synergy between these two proteins may occur at least partially at the level of binding. The potent synergistic actions of these proteins can also be demonstrated against serum-resistant clinical isolates of encapsulated E. coli tested in whole blood and plasma ex vivo, suggesting that such combined action may contribute to host defense in vivo.

MeSH Terms
Animals Anti-Bacterial Agents/pharmacology Antimicrobial Cationic Peptides Blood Bactericidal Activity Blood Proteins/pharmacology Defensins Drug Synergism Escherichia coli/drug effects,growth & development,metabolism Membrane Proteins Phospholipids/metabolism Rabbits
Chemicals
Anti-Bacterial Agents Antimicrobial Cationic Peptides Blood Proteins Defensins Membrane Proteins Phospholipids bactericidal permeability increasing protein
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Levy O
Department of Microbiology, New York University School of Medicine, New York 10016.
Ooi C E
Weiss J
Lehrer R I
Elsbach P
References (34)
34 references, click to expand
  1. Characterization of bovine neutrophil antibacterial polypeptides which bind to Escherichia coli.
    Infect Immun. 1993 Mar;61(3):966-9 PMID: 8432616
  2. Human neutrophil azurocidin synergizes with leukocyte elastase and cathepsin G in the killing of Capnocytophaga sputigena.
    Infect Immun. 1992 Nov;60(11):4973-5 PMID: 1399008
  3. Bactericidal/permeability increasing protein and host defense against gram-negative bacteria and endotoxin.
    Curr Opin Immunol. 1993 Feb;5(1):103-7 PMID: 8452666
  4. Antibiotic peptides and serine protease homologs in human polymorphonuclear leukocytes: defensins and azurocidin.
    Curr Opin Immunol. 1993 Feb;5(1):97-102 PMID: 8452681
  5. Functional and chemical characterization of Hymenoptaecin, an antibacterial polypeptide that is infection-inducible in the honeybee (Apis mellifera).
    J Biol Chem. 1993 Apr 5;268(10):7044-54 PMID: 8463238
  6. Defensins: antimicrobial and cytotoxic peptides of mammalian cells.
    Annu Rev Immunol. 1993;11:105-28 PMID: 8476558
  7. The humoral antibacterial response of Drosophila.
    FEBS Lett. 1993 Jun 28;325(1-2):63-6 PMID: 8513894
  8. Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine.
    Infect Immun. 1993 Jul;61(7):2978-84 PMID: 8514403
  9. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide.
    Immunobiology. 1993 Apr;187(3-5):417-29 PMID: 8330906
  10. Plasma defensin concentrations are elevated in patients with septicemia or bacterial meningitis.
    J Lab Clin Med. 1993 Aug;122(2):202-7 PMID: 8340706
  11. Protective effect of a recombinant amino-terminal fragment of bactericidal/permeability-increasing protein in experimental endotoxemia.
    J Infect Dis. 1993 Nov;168(5):1307-10 PMID: 8228369
  12. Microbicidal mechanisms of human granulocytes: synergistic effects of granulocyte elastase and myeloperoxidase or chymotrypsin-like cationic protein.
    Infect Immun. 1976 Dec;14(6):1276-83 PMID: 12111
  13. Separation and purification of a potent bactericidal/permeability-increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes. Observations on their relationship.
    J Biol Chem. 1979 Nov 10;254(21):11000-9 PMID: 500619
  14. Sensitivity of K1-encapsulated Escherichia coli to killing by the bactericidal/permeability-increasing protein of rabbit and human neutrophils.
    Infect Immun. 1982 Dec;38(3):1149-53 PMID: 6759406
  15. Primary structures of MCP-1 and MCP-2, natural peptide antibiotics of rabbit lung macrophages.
    J Biol Chem. 1983 Dec 10;258(23):14485-9 PMID: 6643497
  16. Purification and antibacterial activity of antimicrobial peptides of rabbit granulocytes.
    Infect Immun. 1984 Jul;45(1):150-4 PMID: 6735465
  17. Primary structures of three human neutrophil defensins.
    J Clin Invest. 1985 Oct;76(4):1436-9 PMID: 4056036
  18. Relation between binding and the action of phospholipases A2 on Escherichia coli exposed to the bactericidal/permeability-increasing protein of neutrophils.
    Biochim Biophys Acta. 1987 Aug 15;920(3):221-5 PMID: 3300783
  19. Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria. Implications and use as a means of purification.
    J Immunol. 1989 Apr 15;142(8):2807-12 PMID: 2539411
  20. Antibiotic proteins of human polymorphonuclear leukocytes.
    Proc Natl Acad Sci U S A. 1989 Jul;86(14):5610-4 PMID: 2501794
  21. What is synergy?
    Pharmacol Rev. 1989 Jun;41(2):93-141 PMID: 2692037
  22. Separation of sublethal and lethal effects of the bactericidal/permeability increasing protein on Escherichia coli.
    J Clin Invest. 1990 Mar;85(3):853-60 PMID: 2179269
  23. Purification of a cellular (granulocyte) and an extracellular (serum) phospholipase A2 that participate in the destruction of Escherichia coli in a rabbit inflammatory exudate.
    J Biol Chem. 1990 Apr 25;265(12):6675-81 PMID: 2182625
  24. Bacterial phospholipid hydrolysis enhances the destruction of Escherichia coli ingested by rabbit neutrophils. Role of cellular and extracellular phospholipases.
    J Clin Invest. 1990 Jun;85(6):1925-35 PMID: 2189895
  25. Separation of sublethal and lethal effects of polymorphonuclear leukocytes on Escherichia coli.
    J Clin Invest. 1990 Aug;86(2):631-41 PMID: 2200807
  26. Isolation of two isoforms of a novel 15-kDa protein from rabbit polymorphonuclear leukocytes that modulate the antibacterial actions of other leukocyte proteins.
    J Biol Chem. 1990 Sep 15;265(26):15956-62 PMID: 2203792
  27. Antimicrobial polypeptides of human neutrophils.
    Blood. 1990 Dec 1;76(11):2169-81 PMID: 2257291
  28. Ultrasensitive assays for endogenous antimicrobial polypeptides.
    J Immunol Methods. 1991 Mar 21;137(2):167-73 PMID: 1901580
  29. Activation of plasma systems and blood cells by endotoxin in rabbits.
    Inflammation. 1991 Apr;15(2):81-90 PMID: 1649134
  30. Killing of gram-negative bacteria by lactoferrin and lysozyme.
    J Clin Invest. 1991 Oct;88(4):1080-91 PMID: 1918365
  31. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin.
    J Immunol. 1992 Jan 15;148(2):532-7 PMID: 1729370
  32. Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line.
    J Clin Invest. 1992 May;89(5):1478-84 PMID: 1569186
  33. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
    J Clin Invest. 1992 Sep;90(3):1122-30 PMID: 1522221
  34. Antibacterial 15-kDa protein isoforms (p15s) are members of a novel family of leukocyte proteins.
    J Biol Chem. 1993 Mar 15;268(8):6058-63 PMID: 8449963
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1994-08-00
Pages
672-82
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC296145
Subset
IM
Grants
NIGMS NIH HHS · 5T32GM07308 · United States
NIAID NIH HHS · AI18571 · United States
NIDDK NIH HHS · R37DK05472 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com